in patients with long qt syndrome , cardiac disease , or patients taking other qt-prolonging medications , this can increase risk for life-threatening arrhythmias taking clarithromycin with other medications that are metabolized by cyp3a4 may lead to unexpected increases or decreases in drug levels concurrent therapy with calcium channel blocker may increase risk of hypotension , kidney failure , and death , compared to pairing calcium channel blockers with azithromycin , a drug similar to clarithromycin but without cyp3a4 inhibition it is readily absorbed , and diffuses into most tissues and phagocytes 